IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice

Clinical and Experimental Immunology

Volumn 145, Issue 1, 2006, Pages 108-115

  Vassilev, T ^a   Mihaylova, N ^a   Voynova, E ^a   Nikolova, M ^b   Kazatchkine, M ^c   Kaveri, S ^c  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Autoimmunity; Igm; Immunotherapy; Ivig; SCID mice

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOID CELL LINE; MOUSE; MOUSE STRAIN; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BIOLOGICAL MARKERS; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; LYMPHOCYTE ACTIVATION; MICE; MICE, SCID; PHOSPHATIDYLSERINES; T-LYMPHOCYTES;

EID: 33745130695     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03098.x     Document Type: Article

References (45)

1. Hurez V Kazatchkine MD Vassilev T et al. Pooled normal human polyspecific IgM contains neutrlyzing antiidiotypes to IgG autoantibdies of autoimmune patients and protects from autoimmune disease. Blood 1997 90 : 4004 13.
2. Adib M Ragimbeau J Avrameas S Ternynck T. IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol 1990 145 : 3807 13.
3. Melero J Tarrago D Nunez-Roldan A Sanchez B. Human polyreactive IgM monoclonal antibodies with blocking activity against self-reactive IgG. Scand J Immunol 1997 45 : 393 400.
4. Stahl D Lacroix-Desmazes S Heudes D Mouthon L Kaveri SV Kazatchkine MD. Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia. Blood 2000 95 : 328 35.
5. Ronda N Haury M Nobrega A Kaveri SV Coutinho A Kazatchkine MD. Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int Immunol 1994 6 : 1651 60.
6. Ehrenstein MR Cook HT Neuberger MS. Deficiency in serum immunoglobulin (Ig) M predisposes to development of IgG autoantibodies. J Exp Med 2000 191 : 1253 8.
7. Boes M Schmidt T Chen J. Accelerated Development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 2000 97 : 1184 9.
8. Vassilev T Yamamoto M Aissaoui A Bonnin E Berih-Aknin S Kazatchkine M Kaveri SK. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice. Eur J Immunol 1999 29 : 2436 42.
9. Ohlin M Sundquist V-A Wahren B Gilliam G Ruden U Gombert F Borrebaeck CAK. Characterisation of human monoclonal antibodies directed against the pp65 kD matrix antigen of human cytomegalovirus. Clin Exp Immunol 1991 88 : 508 14.
10. Van Schaik IN Lundkvist I Vermeulen M Brand A. Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 1992 12 : 325 34.
11. Tary-Lehmann M Saxon A Lehmann PV. The human immune system in hu-PBL-SCID mice. Immunol Today 1995 16 : 529 33.
12. Varambally S Bar-Dayan Y Bayry J et al. Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells. Int Immunol 2004 16 : 517 24.
13. Prasad NK Papoff G Zeuner A Bonnin E Kazatchkine MD Ruberti G Kaveri SV. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 1998 161 : 3781 90.
14. Pilarski LM Andrews EJ Serra HM Ledbetter JA Ruether BA Mant MJ. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Am J Hematol 1989 30 : 53 60.
15. Jonsson V Wiik A. Hou Jensen K et al. Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. J Intern Med 1999 245 : 277 86.
16. Jonsson V Kierkegaard A Salling S Molander S Andersen LP Christiansen M Wiik A. Autoimmunity in Waldenstrom's macroglobulinaemia. Leukemia Lymphoma 1999 34 : 373 9.
17. Owen RG Lubenko A Savage J Parapia LA Jack AS Morgan GJ. Autoimmune thrombocytopenia in Waldenstrom's macroglobulinemia. Am J Hematol 2001 66 : 116 9.
18. Marches R Vitetta ES Uhr JW. A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas. Proc Natl Acad Sci USA 2001 98 : 3434 9.
19. Bendtzen K Hansen MB Ross C Poulsen LK Svenson M. Cytokines and autoantibodies to cytokines. Stem Cells (Dayt) 1995 13 : 206 22.
20. Bayry J Lacroix-Desmazes S Delignat S Mouthon L Weill B Kazatchkine M Kaveri S. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon- present in serum from patients with systemic lupus erythematosus. Arthr Rheum 2003 48 : 3497 502.
21. Mouthon L Kaveri SV Spalter SH Lacroix-Desmazes S Lefranc C Desai R Kazatchkine MD. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol 1996 104 ( Suppl. 1 3 9.
22. Samuelsson A Towers TL Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001 291 : 484 6.
23. Bruhns P Samuelsson A Pollard JW Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune diseases. Immunity 2003 18 : 573 81.
24. Nakamura T Kubagawa H Ohno T Cooper MD. Characterization of an IgM Fc-binding receptor on human T cells. J Immunol 1993 151 : 6933 41.
25. Monteiro RC Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol 2003 21 : 177 204.
26. Shibuya A Sakamoto N Shimizu Y et al. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 2000 1 : 441 6.
27. Phillips-Quagliata JM Patel S Han JK et al. The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor. J Immunol 2000 165 : 2544 55.
28. Sakamoto N Shibuya K Shimizu Y et al. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur J Immunol 2001 31 : 1310 6.
29. Jozsi M Prechl J Bajtay Z Erdei A. Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes. J Immunol 2002 168 : 2782 8.
30. David K Ollert MW Vollmert C Heiligtag S Eickhoff B Erttmann R Bredehorst R Vogel CW. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen. Cancer Res 1999 59 : 3768 75.
31. Boes M Prodeus AP Schmidt T Carroll MC Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998 188 : 2381 6.
32. Bar Dayan Y Bonnin E Bloch M Schweitzer R Ravid M Kazatchkine MD Kaveri SV. Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation. Scand J Immunol 2000 51 : 408 14.
33. Baker N Ehrenstein MR. Cutting edge. selection of B lymphocyte subsets is regulated by natural IgM. J Immunol 2002 169 : 6686 90.
34. Coutinho A Kazatchkine MD Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995 7 : 812 8.
35. Kearney JF Bartels J Hamilton AM Lehuen A Solvason N Vakil M. Development and function of the early B cell repertoire. Int Rev Immunol 1992 8 : 247 57.
36. Bieber A Asakura K Warrington A Kaveri SV Rodriguez M. Antibody-mediated remyelination: relevance to multiple sclerosis. Mult Scler 2000 6 ( Suppl. 2 S1 5.
37. Stangel M Bernard D. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination. J Neuroimmunol 2003 138 : 25 30.
38. Tinguely C Schaller M Nydegger UE. Mononuclear cells ingest E. coli opsonized by investigational intravenous immunoglobulin preparations in the absence of complement more efficiently than polymorphonuclear phagocytes. Transfus Apher Sci 2001 25 : 43 50.
39. Rieben R Roos A Muizert Y Tinguely C Gerritsen AF Daha MR. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 1999 93 : 942 51.
40. Lissner R Struff WG Autenrieth IB Woodcock BG Karch H. Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg Suppl 1999 584 : 17 25.
41. Pilz G Appel R Kreuzer E Werdan K. Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis. Chest 1997 111 : 419 26.
42. Kress HG Scheidewig C Schmidt H Silber R. Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med 1999 27 : 1281 7.
43. Tugrul S Ozcan PE Akinci O Seyhun Y Cagatay A Cakar N Esen F. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]. Crit Care 2002 6 : 357 62.
44. Nachbaur D Herold M Gachter A Niederwieser D. Modulation of alloimmune response in vitro by an IgM-enriched immunoglobulin preparation (Pentaglobin). Immunology 1998 94 : 279 83.
45. Zander AR Zabelina T Kroger N et al. Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow. Bone Marrow Transpl 1999 23 : 889 93.